FBIO Valuation

Fortress Biotech Inc

Add to Watchlist

Advanced Chart

1.410

-0.040(-2.760%)

Overview
Forecast
Valuation

FBIO Relative Valuation

FBIO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, FBIO is overvalued; if below, it's undervalued.

Historical Valuation

Fortress Biotech Inc (FBIO) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.58 is considered Undervalued compared with the five-year average of 1.97. The fair price of Fortress Biotech Inc (FBIO) is between 81.31 to 88.18 according to relative valuation methord. Compared to the current price of 1.41 USD , Fortress Biotech Inc is Undervalued By 98.27%.

Relative Value

Fair Zone

81.31-88.18

Current Price：1.41

98.27%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.78

P/B

Median3y

1.90

Median5y

2.52

-189.88

FCF Yield

Median3y

-253.57

Median5y

-166.88

Competitors Valuation Multiple

The average P/S ratio for FBIO's competitors is 144.27, providing a benchmark for relative valuation. Fortress Biotech Inc Corp (FBIO) exhibits a P/S ratio of 0.58, which is -99.60% above the industry average. Given its robust revenue growth of -87.47%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap